YU23301A - Postupak za dobijanje supstituisanih piridina - Google Patents

Postupak za dobijanje supstituisanih piridina

Info

Publication number
YU23301A
YU23301A YU23301A YUP23301A YU23301A YU 23301 A YU23301 A YU 23301A YU 23301 A YU23301 A YU 23301A YU P23301 A YUP23301 A YU P23301A YU 23301 A YU23301 A YU 23301A
Authority
YU
Yugoslavia
Prior art keywords
substituted pyridines
preparing substituted
preparing
pyridines
obtaing
Prior art date
Application number
YU23301A
Other languages
English (en)
Inventor
Robert Lee Dow
Seven Roy Schneider
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU23301A publication Critical patent/YU23301A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/188—Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Postupak za dobijanje jedinjenja formule gde su n, R1, R2, R3 i X definisani gore, koje se koristi kao intermedijar u sintezi agonista Гџ-adrenergijskog receptora.[Process for obtaing compounds of the formula wherein N, R1, R2, R3 and x are defined above, used as intermediary in the synthesis of agonists of B-adrenergic receptor.
YU23301A 2000-03-31 2001-03-27 Postupak za dobijanje supstituisanih piridina YU23301A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19377200P 2000-03-31 2000-03-31

Publications (1)

Publication Number Publication Date
YU23301A true YU23301A (sh) 2003-04-30

Family

ID=22714938

Family Applications (1)

Application Number Title Priority Date Filing Date
YU23301A YU23301A (sh) 2000-03-31 2001-03-27 Postupak za dobijanje supstituisanih piridina

Country Status (26)

Country Link
US (4) US6518431B2 (sh)
EP (1) EP1138685B1 (sh)
JP (1) JP2001316393A (sh)
KR (2) KR100435128B1 (sh)
CN (1) CN1191235C (sh)
AR (1) AR033812A1 (sh)
AT (1) ATE267204T1 (sh)
AU (1) AU782272B2 (sh)
BR (1) BR0101280A (sh)
CA (1) CA2342571A1 (sh)
CZ (1) CZ20011194A3 (sh)
DE (1) DE60103317T2 (sh)
DK (1) DK1138685T3 (sh)
ES (1) ES2217090T3 (sh)
HK (1) HK1038019A1 (sh)
HU (1) HUP0101332A3 (sh)
ID (1) ID29728A (sh)
MX (1) MXPA01003383A (sh)
PL (1) PL346805A1 (sh)
PT (1) PT1138685E (sh)
RU (1) RU2223956C2 (sh)
SI (1) SI1138685T1 (sh)
TR (1) TR200401359T4 (sh)
TW (1) TW555761B (sh)
YU (1) YU23301A (sh)
ZA (1) ZA200102538B (sh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190122333A (ko) 2018-04-20 2019-10-30 사단법인 한국지능형교통체계협회 스터드 레일 피팅
KR102037602B1 (ko) 2018-04-20 2019-10-28 사단법인 한국지능형교통체계협회 저상 버스용 고정 바를 갖춘 휠체어 잠금장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
AU712057B2 (en) * 1996-06-07 1999-10-28 Merck & Co., Inc. Oxadiazole benzenesulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
US5792871A (en) 1996-07-22 1998-08-11 Merck & Co., Inc. Process for N-Boc-N-(R)-2(3-pyridyl)-2-hydroxy-ethyl)-N-2(4-aminophenyl)ethyl amine and 2-(4-aminophenyl)-N-2-(2(R)-hydroxy-2-phyridin-S-yl-ethyl)acetamide
PL334833A1 (en) * 1997-01-28 2000-03-27 Merck & Co Inc Thiazolobenzenosulphonamides as beta3 agonists for treating diabetes and obesity
EP1153919A4 (en) * 1999-02-16 2002-10-02 Kaneka Corp SUBSTITUTED ACETYLPYRIDINE DERIVATIVES AND PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR OPTICALLY ACTIVE BETA3 ADRENERGIC RECEPTOR AGONIST USING THE SAME

Also Published As

Publication number Publication date
PT1138685E (pt) 2004-08-31
ES2217090T3 (es) 2004-11-01
KR20010095192A (ko) 2001-11-03
RU2223956C2 (ru) 2004-02-20
KR100435128B1 (ko) 2004-06-09
MXPA01003383A (es) 2005-08-26
ZA200102538B (en) 2002-09-30
EP1138685A3 (en) 2003-04-02
EP1138685B1 (en) 2004-05-19
PL346805A1 (en) 2001-10-08
AU782272B2 (en) 2005-07-14
US20030114670A1 (en) 2003-06-19
ID29728A (id) 2001-10-04
AR033812A1 (es) 2004-01-07
DE60103317T2 (de) 2005-06-16
CN1320596A (zh) 2001-11-07
EP1138685A2 (en) 2001-10-04
HUP0101332A3 (en) 2004-07-28
HUP0101332A2 (en) 2002-10-28
US6518431B2 (en) 2003-02-11
HK1038019A1 (en) 2002-03-01
BR0101280A (pt) 2001-11-06
US6844441B2 (en) 2005-01-18
JP2001316393A (ja) 2001-11-13
ATE267204T1 (de) 2004-06-15
KR100481603B1 (ko) 2005-04-08
AU3334801A (en) 2001-12-13
TR200401359T4 (tr) 2004-08-23
DK1138685T3 (da) 2004-08-09
KR20030072295A (ko) 2003-09-13
US6670480B2 (en) 2003-12-30
CZ20011194A3 (cs) 2002-02-13
TW555761B (en) 2003-10-01
US20050113578A1 (en) 2005-05-26
DE60103317D1 (de) 2004-06-24
SI1138685T1 (en) 2004-12-31
CN1191235C (zh) 2005-03-02
US20020077478A1 (en) 2002-06-20
HU0101332D0 (en) 2001-06-28
CA2342571A1 (en) 2001-09-30
US20040133005A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
MXPA03008754A (es) Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor.
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
MY129613A (en) Cannabinoid receptor binding compounds
NZ519241A (en) Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it
IL155875A0 (en) Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
MXPA02000973A (es) Benzofurilpiperazinas y benzofurilhomopiperazinas: agonistas de serotonina.
MXPA02011370A (es) Iminoazinas substituidas.
IL155702A0 (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5-ht2 receptor
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
GB9822473D0 (en) Chemical compounds
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
BG106930A (en) Substituted phenyl-piperazine derivatives, their preparation and use
YU1302A (sh) Derivati aminotiazola i njihova primena kao liganada crf receptora
ES2159488A1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifugica.
NZ513041A (en) N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists; their preparation and medicaments containing them
BG106002A (en) Process for preparing pesticidal intermediates
TR200402546T4 (tr) Taksan türevleri hazırlamak için işlem.
YU23301A (sh) Postupak za dobijanje supstituisanih piridina
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
AU2001293791A1 (en) Process for the preparation of vitronectin receptor antagonists
TR200002755T2 (tr) Aracı hazırlamak için süreç.
IL141009A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof
EP1065202A4 (en) 6- (ALPHA-FLUOROALKYL) -4-PYRIMIDONES AND THEIR PRODUCTION PROCESS
PL375350A1 (en) Indol derivatives and their use as 5-ht ligands